Related Experiment Videos
Transdermal hormone replacement therapy, serum lipids and lipoproteins
1Wynn Division of Metabolic Medicine, Imperial College School of Medicine, National Heart and Lung Institute, London, UK.
British Journal of Clinical Practice. Supplement
|September 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
COVID-19 pandemic impact on adolescent mental health: a reassessment accounting for development.
European child & adolescent psychiatry·2024
Effect of hormone replacement therapy on intervertebral disc height.
Climacteric : the journal of the International Menopause Society·2023
Cardiometabolic health in premature ovarian insufficiency.
Climacteric : the journal of the International Menopause Society·2021
Lower respiratory tract infection in the community: associations between viral aetiology and illness course.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
The menopausal hot flush: a review.
Climacteric : the journal of the International Menopause Society·2017
Treatment of dyslipidaemias with fluvastatin.
British journal of clinical practice. Supplement·2009
Lipoprotein(a) as a marker for coronary heart disease.
British journal of clinical practice. Supplement·2009
Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
British journal of clinical practice. Supplement·2009
Risk factor management: the cardiologist's perspective.
British journal of clinical practice. Supplement·2009
Fluvastatin in combination with other lipid-lowering agents.
British journal of clinical practice. Supplement·2009
The patient at risk: who should we be treating?
British journal of clinical practice. Supplement·2009
Occurrence of Infusion Associated Reactions and Antidrug Antibodies in Enzyme Replacement Therapy for Fabry Disease and the Effect of Preventive Measures.
Journal of inherited metabolic disease·2026
Amyloid-Related Imaging Abnormalities Summit Special Proceedings: Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease.
Journal of the American Heart Association·2026
Toward Personalized Theranostics: A Modular PET Platform for Antibody-Based Imaging and Therapy.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Targeted Degradation of KAT6A: Expanding the Therapeutic Frontier of Epigenetic Drug Discovery.
ACS medicinal chemistry letters·2026